Skip to content

Clinical trials

Phase 3 Lewy Body Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lewy Body Disease Phase: Phase 3 Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20112
20171
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ACADIA Pharmaceuticals Inc.1
Assistance Publique - Hôpitaux de Paris1
Eisai Co., Ltd.1
GE Healthcare1
Neurological Research Center1
Tim Lau1
University of Alberta1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lewy Body Disease7
Dementia3
Alzheimer Disease2
Cognitive Dysfunction2
Dementia, Vascular2
Brain Neoplasms1
Congenital Hyperinsulinism1
Corticobasal Degeneration1
Hallucinations1
Neuroblastoma1

Trials

Showing 76 to 7 of 7. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.